Director’s View

It gives me great pleasure to welcome you to our website. We began this company with nothing much more than a pocket full of dreams. Ours is a young company, in years and in attitude. We dream big and we are not afraid to try out even seemingly impossible ideas. We are driven to make a mark in every field that we enter. We are sometimes impatient with ourselves, but we have no fear of failure. We realize that some our most significant learnings have come from our failures. And they have become stepping stones to our most significant successes.

We want to drive the market – we don’t want to be driven by it. We have been launching niche products, changing our processes, changing the consumer’s expectations and changing mindsets at an amazingly rapid pace. But there are a few things we will not change. Our passion for life. Life is our lifetime passion.

Our objective to create a sustainable enterprise in the cardiovascular and diabetic branded generics segment. We would achieve this by

  • Focus on brand building and driving competitive differentiation for selected products.
  •  Winning with the right customers, excelling in customer and service intimacy.
  • Recruiting, training, developing and retaining the right passionate people by ensuring due recognition for personal and professional growth.

In our business plan, the following four principles are laid down which stress that the longer term business priorities reconfirm our standards of behavior :

  • Customer Value : We would add value to our customers’ businesses with solutions that satisfy their unique needs.
  •  Creative : We would constantly generate new ideas in differentiating our products from the rest of competitors.
  •  Expertise : We would share professional resources, knowledge, our competencies and achievements with our customers.
  • Customer Value : We would add value to our customers’ businesses with solutions that satisfy their unique needs.

What the future holds for Elene pharma? Even taking into consideration the global macroeconomic volatilities, I would confidently say it is promising. There are a number of things on our radar :

  • Expand branded generics business to have all India presence;
  •  Expand product portfolio through a consistent pipeline;
  • Develop Research and Development capabilities into value-generating space and complex delivery mechanism platforms;
  • Explore new avenues (Ophthalmics, Biosimilars and Peptides)

It would be indeed satisfying for all of us to witness a fulfilling journey of our enterprise that is deeply motivated by its commitment to healthcare and create value for Indian society. Our group looks to the future with confidence, driven by an inspiring vision, values of trust and vitality powered by dedicated human resources team